Yoshida et al. [20], using RECK mRNA-targeting siRNA interference, reported that the expression of MMP-2 protein and its consequent invasive capability increased in pituitary adenomas cells after RECK had been downregulated. The gene discussed is RECK; the disease is pituitary gland adenoma.